CGC
Price
$1.34
Change
-$0.03 (-2.19%)
Updated
Sep 26 closing price
Capitalization
420.68M
40 days until earnings call
INCR
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
Sep 26 closing price
Capitalization
79.59M
52 days until earnings call
Interact to see
Advertisement

CGC vs INCR

Header iconCGC vs INCR Comparison
Open Charts CGC vs INCRBanner chart's image
Canopy Growth
Price$1.34
Change-$0.03 (-2.19%)
Volume$10.53M
Capitalization420.68M
Intercure
Price$1.46
Change+$0.02 (+1.39%)
Volume$58.31K
Capitalization79.59M
CGC vs INCR Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. INCR commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and INCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CGC: $1.34 vs. INCR: $1.46)
Brand notoriety: CGC: Notable vs. INCR: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 49% vs. INCR: 148%
Market capitalization -- CGC: $420.68M vs. INCR: $79.59M
CGC [@Pharmaceuticals: Generic] is valued at $420.68M. INCR’s [@Pharmaceuticals: Generic] market capitalization is $79.59M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileINCR’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • INCR’s FA Score: 1 green, 4 red.
According to our system of comparison, INCR is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while INCR’s TA Score has 3 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • INCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CGC is a better buy in the short-term than INCR.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -2.19% price change this week, while INCR (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

INCR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($421M) has a higher market cap than INCR($79.6M). INCR YTD gains are higher at: -8.176 vs. CGC (-51.095).
CGCINCRCGC / INCR
Capitalization421M79.6M529%
EBITDA-410.31MN/A-
Gain YTD-51.095-8.176625%
P/E RatioN/A24.99-
Revenue275MN/A-
Total Cash144MN/A-
Total Debt328MN/A-
FUNDAMENTALS RATINGS
CGC vs INCR: Fundamental Ratings
CGC
INCR
OUTLOOK RATING
1..100
6564
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9987
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (60) in the Servicestothe Health Industry industry is somewhat better than the same rating for CGC (93) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew somewhat faster than CGC’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew similarly to CGC’s over the last 12 months.

INCR's SMR Rating (87) in the Servicestothe Health Industry industry is in the same range as CGC (99) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew similarly to CGC’s over the last 12 months.

CGC's Price Growth Rating (62) in the Agricultural Commodities Or Milling industry is in the same range as INCR (64) in the Servicestothe Health Industry industry. This means that CGC’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (5) in the Servicestothe Health Industry industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that INCR’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCINCR
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 21 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRPI0.07N/A
+3.97%
NRP Stone, Inc.
CSHX69.510.76
+1.11%
Cashmere Valley Bank
VTTGF355.60N/A
N/A
VAT Group AG
TGMR0.06N/A
N/A
Troy Gold & Mineral Corp.
PROCF1.12N/A
N/A
Procaps Group, S.A.

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been loosely correlated with ACB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-2.19%
ACB - CGC
65%
Loosely correlated
-1.82%
TLRY - CGC
61%
Loosely correlated
-3.36%
OGI - CGC
61%
Loosely correlated
-3.43%
CRON - CGC
57%
Loosely correlated
-0.38%
NBIX - CGC
31%
Poorly correlated
+0.79%
More

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+1.39%
PHCUF - INCR
26%
Poorly correlated
N/A
TLRY - INCR
22%
Poorly correlated
-3.36%
QNTM - INCR
22%
Poorly correlated
-4.39%
DRRX - INCR
21%
Poorly correlated
N/A
CGC - INCR
21%
Poorly correlated
-2.19%
More